1Crisci A. Le membrane L-PRF utili in chirurgia. (2015) Journal of Plastic Dermatology 2:75-90

2Crisci A, Placido F, Crisci M, Bosco A. (2015) A new instrument aid of plastic surgeon: membranes L-PRF (Pletelet-Rich-Fibrin). Update in Plastic Surgery 3:162-72

3Crisci A, Serra E, Cardillo F, Crisci M. (2017) Selezione di un modello animale pertinente per la prova degli effetti in vitro della fibrina ricca di leucociti e piastrine di Choukroun (L-PRF equino). Nota su un protocollo standardizzato proposto per l’uso clinico e l’uso di L-PRF Wound Box®. V.P.E. 1: 41-50

4Crisci A, Lombardi D, Serra E, Lombardi G, Cardillo F, Crisci M. (2017) Standardized protocol proposed for clinical use of L-PRF and the use of L-PRF Wound Box®. J Unexplored Med Data 2: 77-87

5Marotta G, Licito A, Serra E, Benincasa G, Crisci A. (2018) Evaluation of genotyping methods and costs for IL1 α polymorphisms in Platelet Rich-Plasma (PRP); viewpoint for therapy on the diabetic foot ulcers. Europ. Rev. Med. Pharmac. Sci. 22: 575-77

6Crisci A, Benincasa G, Crisci M, Crisci F. (2018) Leukocyte Platelet-Rich Fibrin (L-PRF), a new bio membrane useful in tissue repair: basic science and literature review. Bio interface Research in Applied Chemistry 5: 3635-43

7Lundquist R, Dziegiel MH, Agren MS. (2008) Bioactivity and stability of endogenous fibrogenic factors in platelet rich fibrin. Wound Repair Regen 16: 356

8Lundquist R, et al. (2013) Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds. Wound Repair Regen 21: 66

9Clipet F, et al. (2012) In vitro effects of Choukroun’s platelet-rich fibrin conditioned medium on 3 different cell lines implicated in dental implantology. Implant Dent 21: 51

10Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, et.al. (2014) Advanced Platelet-Rich Fibrin: A New Concept for Cell- Based Tissue Engineering by Means of Inflammatory Cells. Journal of Oral Implantology 40: 679-689

11Choukroun J. (2014) Advanced-PRF and i-PRF: platelet concentrates or blood concentrates? Journal of periodontal medicine and clinical practice JPMCP 1: 1- 3

12Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. (2017) Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Invest

13Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ. (2016) Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Invest

14Burnouf T, Chou, M-L, Wu U-W, Su C-Y, Lee L-W. (2013) Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. TRANSFUSION 53: 138-46

15Crisci A, De Crescenzo U, Crisci M, (2018) Platelet-Rich Concentrates (L-PRF, PRP) in Tissue Regeneration: Control of Apoptosis and Interactions with Regenerative Cells. J Clin Mol Med 3: 5-2

16Bayer A, Lammel J, Rademacher F, Grob J, Siggelkow M, Lippross S, et.al. (2016) Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes. Experimental Dermatology 25: 460–465

17Crisci A, Marotta G, Licito A, Serra E, Benincasa G, Crisci M. (2018) Use of leukocyte platelet (L-PRF) rich fibrin in diabetic foot ulcer with osteomyelitis (three clinical cases report). Diseases 6: 30

18Crisci A, Marotta G, Benincasa G, Crisci M. (2018) L-PRF (fibrina ricca in leucociti e piastrine): uso in tre casi di ulcera diabetica con osteomielite cronica. Journal A.M.D. 213: 197-203

19Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J. (2016) Optimized Platelet-Rich Fibrin with the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response. J Periodontol. 88: 112-21

20Del Fabbro M, Bortolin M, Taschieri S, Ceci C, Weinstein RL. (2016) Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence. Platelets 27:276–85

21Burnouf T, Chou, M-L, Wu U-W, Su C-Y, Lee L-W. (2013) Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. TRANSFUSION 53: 138-46

22Cieslik-Bielecka A, Dohan Ehrenfest DM, Lubkowska A, Bielecki T. (2012) Microbicidal properties of leukocyte- and platelet-rich plasma/fibrin (L-PRP/L-PRF): new perspectives. Journal of Biological Regulators & Homeostatic Agents 26: 43-52

23Anitua E, Muruzabal F, Orive G. (2011) Antimicrobial properties of plasma rich in growth factors (PRGF-ENDOREST). Science against microbial pathogens; A. Méndez-Vilas (Ed) FORMATEX 414-21

24Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends in Biotechnology 27

25Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. (2007) Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg 89-B: 417-20

26Zalavras CG, Patzakis MJ, Holton P. (2004) Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop 427: 86-93

27Sause WE, Buckley PT, Strohl WR, Lynch AS, Torres VJ. (2016) Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections. Trends in Pharmacological Sciences 37: 231-41

28Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, et.al. (2016) Candida Albicans pathogenesis: fitting within the host-microbe damage response framework. Infect Immun 84: 2724 –739

29Marsh PD, Zaura E. Dental biofilm: ecological interactions in health and disease. (2017) J Clin Periodontol 18: S12–S22.

30Tan Y-Q, Yeaman MR, Selsted ME. (2002) Antimicrobial Peptides from Human Platelets Infection and Immunity 70 12: 6524–33

31El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, et.al. (2007). Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 78: 661–9

32Yajamanya SR, Chatterjee A, Babu CN, Karunanithi D. (2016). Fibrin network pattern changes of platelet-rich fibrin in young versus old age group of individuals: A cell block cytology study. J Indian Soc Periodontol 20: 151–56

33El Bagdadi K, Kubesch A, Yu X, Al Maawi S, Orlowska A, Dias A, Booms P, Dohle E, Sader R, Kirkpatrick CJ, Choukroun J, Ghanaati S. (2017) Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)- based matrices: a proof of concept of LSCC (low speed centrifugation concept). Eur J Trauma Emerg Surg

34Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M. (2017) Regenerative potential of leucocyte- and platelet-rich fibrin. Part B: sinus floor elevation, alveolar ridge preservation, and implant therapy. A systematic review. J Clin Periodontol 44: 225–34

35Moraschini V, dos Santos Porto Barboza E. (2016) Use of Platelet-Rich Fibrin Membrane in the Treatment of Gingival Recession: A Systematic Review and Meta-Analysis. J Periodontol 87: 281-90

36Del Corso M, Vervelle A, Simonpieri A, Jimbo R, Inchingolo F, Sammartino G, et.al. (2012) Current Knowledge and Perspectives for the Use of Platelet- Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 1: Periodontal and Dentoalveolar Surgery. Current Pharmaceutical Biotechnology 13: 1207- 30

37Crisci A., Rescigno C., Crisci M. (2019) La membrana LPRF e suoi derivati utili nella chirurgia del wound care, Italian Journal of Wound Care 1:19-26